NCT01303497 Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas Status COMPLETED Phase PHASE2
NCT01301716 A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema Status COMPLETED Phase PHASE2
NCT01296815 Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity Status COMPLETED Phase PHASE2
NCT01288404 Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium Status COMPLETED Phase NA
NCT01280643 Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status TERMINATED Phase NA
NCT01279681 Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE3
NCT01274624 Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01274273 Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer Status UNKNOWN Phase PHASE2
NCT01270438 Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT01269853 Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA Status RECRUITING Phase PHASE1/PHASE2
NCT01266031 Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01264341 Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT01263834 Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome Status COMPLETED Phase PHASE2/PHASE3
NCT01263782 BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01260506 Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2